Androgen insensitivity syndrome secondary prevention: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Currently there are no established methods to prevent androgen insensitivity syndrome (AIS). However, women with CAIS have decreased bone mineral density, regardless of timing of gonadectomy. | Currently there are no established methods to prevent androgen insensitivity syndrome (AIS). However, women with CAIS have decreased [[bone mineral density]], regardless of timing of gonadectomy. | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Women with CAIS have decreased bone mineral density, regardless of timing of gonadectomy. However, women with PAIS who choose not to undergo gonadectomy do not appear to be at high risk for decreased bone mineral density. The following are advised: <ref name="pmid20301602">{{cite journal |vauthors=Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, Gottlieb B, Trifiro MA |title= |journal= |volume= |issue= |pages= |year= |pmid=20301602 |doi= |url=}}</ref> | Women with CAIS have decreased [[bone mineral density]], regardless of timing of gonadectomy. However, women with PAIS who choose not to undergo gonadectomy do not appear to be at high risk for decreased [[bone mineral density]]. The following are advised: <ref name="pmid20301602">{{cite journal |vauthors=Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Ledbetter N, Mefford HC, Smith RJH, Stephens K, Gottlieb B, Trifiro MA |title= |journal= |volume= |issue= |pages= |year= |pmid=20301602 |doi= |url=}}</ref> | ||
*In addition to estrogen replacement therapy, supplemental calcium and vitamin D are recommended. | *In addition to [[estrogen replacement therapy]], supplemental [[calcium]] and [[vitamin D]] are recommended. | ||
*Regular weight-bearing exercises are encouraged to maintain bone health. | *Regular weight-bearing exercises are encouraged to maintain bone health. | ||
*Bisphosphonate therapy may be indicated for those individuals with evidence of decreased bone mineral density and/or multiple fractures. | *[[Bisphosphonate]] therapy may be indicated for those individuals with evidence of decreased [[bone mineral density]] and/or multiple fractures. | ||
==References== | ==References== | ||
Revision as of 01:28, 16 August 2017
|
Androgen insensitivity syndrome Microchapters |
|
Differentiating Androgen insensitivity syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Androgen insensitivity syndrome secondary prevention On the Web |
|
American Roentgen Ray Society Images of Androgen insensitivity syndrome secondary prevention |
|
Androgen insensitivity syndrome secondary prevention in the news |
|
Blogs on Androgen insensitivity syndrome secondary prevention |
|
Directions to Hospitals Treating Androgen insensitivity syndrome |
|
Risk calculators and risk factors for Androgen insensitivity syndrome secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aravind Reddy Kothagadi M.B.B.S[2]
Overview
Currently there are no established methods to prevent androgen insensitivity syndrome (AIS). However, women with CAIS have decreased bone mineral density, regardless of timing of gonadectomy.
Secondary Prevention
Women with CAIS have decreased bone mineral density, regardless of timing of gonadectomy. However, women with PAIS who choose not to undergo gonadectomy do not appear to be at high risk for decreased bone mineral density. The following are advised: [1]
- In addition to estrogen replacement therapy, supplemental calcium and vitamin D are recommended.
- Regular weight-bearing exercises are encouraged to maintain bone health.
- Bisphosphonate therapy may be indicated for those individuals with evidence of decreased bone mineral density and/or multiple fractures.